Deadline Soon: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz issued a shareholder-solicitation notice reminding Aardvark Therapeutics investors of an October 13, 2026 deadline to seek lead plaintiff status. The lawsuit relates to alleged securities fraud during the period between February 10, 2025 and May 14, 2026, stemming from a Phase 3 clinical trial pause and subsequent FDA clinical hold.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.